expression were detected 16 , the TALE-LSD1 approach allows for only low-throughput approaches, and it remains unclear whether the expression changes were a result of decommissioning an enhancer or due to an indirect effect on gene expression.
Enhancers control development and cellular function, and intensive efforts are ongoing to elucidate cell fate-specific enhancer activity 1, 2 . Indeed, a large number of genomic regions identified by genome-wide association studies of human disease fall within enhancer regions 3, 4 . Thus, there is a pressing need for technologies to functionally annotate cell type-specific enhancer elements that control cellular function.
Engineered derivatives of clustered, regularly interspaced, short palindromic repeats (CRISPR) systems have enabled RNAguided gene regulation through targeting of dCas9-coupled transcriptional regulators to promoter regions [5] [6] [7] [8] [9] [10] , and applicability of this approach in high-throughput contexts has been demonstrated 11, 12 . Although a dCas9-KRAB repressor has previously been used to interfere with enhancer function, the study suggested steric rather than effector-mediated interference 13 . Targeted steric hindrance or nuclease-based disruption of an enhancer is possible, but such approaches require in-depth knowledge of the enhancer, may be inefficient and could have potential side effects such as perturbation of chromatin folding or DNA damage stress responses.
The histone demethylase LSD1 has been previously implicated in repression of enhancers 14, 15 , and transcription activator-like effector (TALE)-LSD1 can target histone modifications that correlate with active enhancers 16 . Although changes in gene Oct6 (Pou3f1)) led to changes in morphology or AP activity, thereby indicating sgRNA-specific changes in cellular state.
For follow-up, we focused on the putative enhancer with the highest differential score, Enh1. Tests of Enh1 in a reporter assay confirmed its ability to enhance expression to levels comparable with those obtained with an ODE sequence (Fig. 1c) . This previously unannotated ESC-specific enhancer is positioned ~10 kb upstream of transcription factor-encoding Tbx3 (Fig. 1d) , a gene previously implicated in the maintenance of pluripotency 20 . We therefore hypothesized that Enh1 may function in the ESC network by regulating Tbx3 expression. Indeed, we detected a relative reduction of Tbx3 mRNA and protein expression upon targeting Enh1 with dCas9-LSD1 ( Fig. 1e and Supplementary  Fig. 8a ). This loss of Tbx3 could be similarly obtained when dCas9-KRAB was used to target Enh1 or the Tbx3 proximal promoter (TPP) but was not observed in control cells. Change in colony morphology and an increase of differentiation-associated markers were detected in a dCas9-effector-and sgRNA-dependent manner ( Fig. 1f, Supplementary Fig. 8 and Supplementary  Table 3 ) concordant with the destabilization of the ESC state. Of note, none of the transcriptomic changes among any of the control conditions exceed twofold. Although this finding does not rule out minor off-target effects, these data support a compelling level of specificity of our system.
Next we sought to dissect the mechanism by which targeting of Enh1, hereafter referred to as Tbx3 distal enhancer (TDE), results in Tbx3 downregulation. We examined a time point at which differential Tbx3 expression levels were detected but changes in cell morphology were not yet observable ( Supplementary Fig. 9a ). Ctrl  TDE  TDE  TPP  TPP  Ctrl  TDE  TPP   11 kb   60  Negative  Mixed   KRAB  LSD1  BAT   40   % OCT4-negative   colonies   20   0   sgRNA   dCas9   Ctrl  Ctrl  Ctrl  ODE  ODE  ODE  OPE  OPE  OPE  OPP  OPP npg capture (3C), we observed a localized peak in interaction frequency between the TDE and the Tbx3 promoter in dCas9-BAT ESCs with a control sgRNA supporting the presence of an enhancer-promoter loop (Supplementary Fig. 9b ). Comparable interaction frequencies were observed for dCas9-LSD1 and dCas9-BAT with TDE sgRNA, indicating that the looping interaction between the Tbx3 promoter and enhancer is not disrupted by dCas9-effector targeting per se.
Conducting chromosome conformation
Investigating local histone modifications in the presence of either dCas9-KRAB or dCas9-LSD1, we observed relative loss of the LSD1 substrate dimethylated histone 3 lysine 4 (H3K4me2) around the enhancer-sgRNA target site in dCas9-LSD1 cells (by 6-to 8-fold) ( Fig. 2a and Supplementary Fig. 10 ). H3K27ac, indicative of active enhancers 2 , was dramatically lost at the enhancer (by 33-to 54-fold) upon dCas9-LSD1 targeting compared to other tested conditions, a finding consistent with prior studies using TALE-LSD1 (ref. 16 ; Fig. 2a and Supplementary Fig. 10) . Changes in H3 occupancy were not detected ( Supplementary  Fig. 10 ). Interestingly, although repressive marks have been previously associated with KRAB-mediated repression 21 , we could not detect concomitant increases in repressive marks, H3K27me3 or H3K9me3, at the enhancer after targeting of any of our constructs ( Fig. 2a) . To further understand the differences between the LSD1 and KRAB effects, we surveyed chromatin state at the Tbx3 promoter. At this promoter, we detected a loss of H3K27ac and an increase of H3K27me3 (~57-fold) and H3K9me3 (~13-fold) when the TDE was targeted with the KRAB effector, but we did not observe substantial changes with LSD1 ( Fig. 2b) . Taken together, these data offer strong evidence that LSD1induced enhancer deactivation results in Tbx3 downregulation, whereas KRAB-mediated Tbx3 downregulation is due to promoter silencing. We therefore caution that the dCas9-KRAB effector, besides having potential side effects such as heterochromatin spreading 21 , is silencing promoter activity rather than decommissioning the target enhancer.
Next, we showed that the LSD1-specific inhibitor TCP (trans-2-phenylcyclopropylamine hydrochloride), previously shown to overcome strong differentiation cues in mESCs, such as loss of Oct4 expression 14 , inhibited the loss of Tbx3 mRNA and protein expression in dCas9-LSD1 cells but not in dCas9-KRAB cells after TDE targeting ( Supplementary Fig. 11 ). This indicates that the loss of Tbx3 expression is directly dependent on the enzymatic activity of LSD1 and that KRAB can repress Tbx3 independently.
We conclude that the dCas9-LSD1 fusion protein allows for an effector-dependent definition of functional, native enhancer elements that help to maintain a given cellular state. Accordingly, dCas9-LSD1 provides a rapid and powerful approach to understanding distal cis-regulatory regions such as enhancers without major disruption of the local genomic architecture. Although we used the Nm dCas9, we expect that similar systems could be built on orthogonal CRISPR-Cas9 systems including the widely used Streptococcus pyogenes dCas9. Further, the use of chromatin modifiers with differential functionality and orthogonal dCas9 systems promises to enable even more complex epigenome engineering. This level of genome control has previously not been achieved with other RNA-guided regulatory technologies such as RNAi. Combined with rapid advances in cell type-specific annotation of regulatory elements and genome-wide association studies, this technology will be instrumental in dissecting the contribution of distal cis-regulatory elements to development and disease.
methods
Methods and any associated references are available in the online version of the paper.
Accession codes. NCBI Gene Expression Omnibus: ATAC-seq and microarray data are available at GSE64059. onLine methods Effector and sgRNA plasmids. A human codon-optimized, nuclease-inactive version of Nm Cas9 was gene synthesized with two SV40 nuclear localization signals and a triple Flag tag (GenScript Technologies) and cloned in-frame with either a BirA affinity tag, a KRAB repressor or LSD1 (for amino acid sequences, see Supplementary Fig. 1) . A Rosa26 CAGS loxP STOP loxP DEST vector was generated by inserting a gateway acceptor cassette into a Rosa26 CAGS loxP STOP loxP targeting vector (a kind gift from A. McMahon). The various dCas9-effector fusions were inserted into the Rosa26 targeting vector by standard gateway cloning.
An sgRNA expression vector was generated by replacing the H1 shRNA and tetO IRES RFP-Puro expression cassettes in a pLV-H1TetO-RFP-Puro lentiviral backbone (Addgene plasmid number 36297) with a U6 Nm sgRNA expression cassette harboring two BsmBI sites for gRNA cloning and EF1α Puro selection cassettes (see Supplementary Fig. 1 for cloning sites) . The Nm sgRNA acceptor and expression cassette was generated as a gene block containing a short form of the tracrRNA (ref. 8 and Supplementary Fig. 1) .
Note: N. meningitidis (Nm) dCas9 is an orthogonal and substantially smaller Cas9 variant to the commonly used Cas9 from S. pyogenes (Sp) that is about 25% longer in its nucleotide sequence. Although not tested in our study, we expect an orthogonal Sp dCas9-LSD1 to perform similarly to the Nm dCas9-LSD1 and to work on alternative PAM sequences. The ability to use either Sp Cas9 or Nm Cas9 broadens the spectrum of potential target sites in the genome 8, 22 , although a thorough test in mammalian cells has to be conducted. Further, off-target effects are currently a major concern of Cas9 systems, and appropriate software and multiple independent sgRNAs should be used to minimize the off-target effects that might influence interpretation of a given study. sgRNA design. sgRNA target sites were obtained by using a custom script (available upon request) that searches for Nm Cas9 PAM sequences NNNNGATT, NNNNGCTT or NNNNGGTT within the enhancer or promoter regions of interest. Bowtie2 was used to map candidate targets to the mouse genome build GRCm38 with sensitive parameters (--local -f -k 10 --verysensitive-local -L 9 -N 1) to detect potential off-target sites. Only sgRNAs were used that had two or more mismatches to other sites in the genome than the selected target site. All our sgRNAs had no other genomic matches at the alignment stringency used. Oligonucleotides for sgRNA cloning were obtained from Integrated DNA Technologies or Life Technologies and are listed in Supplementary Table 4. ESC culture. V6.5 (a kind gift from K. Eggan) and Rosa26targeted mouse ESC lines were maintained on mouse embryonic fibroblast feeder layers in ESC-Media (KnockOUT DMEM (GIBCO, 10829) supplemented with 15% Hyclone FBS (Thermo Scientific, SH30070.03), 1% GlutaMAX (GIBCO, 35050079), 1% NEAA (Cellgro, 25-025-CI), 100 µM β-mercaptoethanol (Invitrogen, 21985023) and 10 3 U/mL LIF) according to standard methodology 23 . ESC lines were routinely tested to confirm the absence of mycoplasma.
Generation of stable Nm dCas9-effector mESCs. V6.5 mESCs were electroporated (230 V, 500 mF) with a Rosa26 targeting construct and selected from day 2-8 with 300 µg/mL Geneticin (Life Technologies, 10131035). Picked clones were screened by PCR analysis for integration ( Supplementary Fig. 2 ; knock-in primers were GCCGCCTAAAGAAGAGGCTGTGCTTTGG (forward) and TACCGTAAGTTATGTAACGCG (reverse)). The following PCR conditions were used: 2-min initial denaturation at 95 °C, 30 cycles with 30-s denaturation at 95 °C, annealing at 50 °C for 30 s, extension at 72 °C for 2 min and a final extension at 72 °C for 5 min. After transient transfection of a Cre recombinase expression plasmid (Addgene plasmid 13775), individual clones were picked, expanded and screened for removal of the loxP-flanked STOP cassette (Supplementary Fig. 2 ; STOP removal primers were TGCTCCTGCCGAGAAAGTATCCATCA TGGC (forward) and CGCCAAGCTCTTCAGCAATATCACGG GTAG (reverse)). The following PCR conditions were used: 1-min initial denaturation at 93 °C and 30 cycles with 20-s denaturation at 95 °C, annealing/extension at 68 °C for 3 min.
Spontaneous differentiation capability of Nm dCas9-effector cells was assessed by injecting ~10 7 undifferentiated cells subcutaneously into 8-to 13-week-old male and female NOD.Cg-Rag1 tm1Mom Il2rg tmWjl /SzJ mice according to institutional guidelines. Teratomas were retrieved and analyzed 3-4 weeks after injection. Hematoxylin and eosin images were acquired on a Nikon Eclipse 90i microscope using a 20× objective (Nikon Plan Fluor 20x/0.50 Ph1 DLL). sgRNA delivery. Rosa26-targeted mESC lines were transduced with lentivirus containing an sgRNA specific to a genomic region of interest. HEK293T cells were used for lentiviral production as described 9 . HEK293T cells were routinely tested to confirm the absence of mycoplasma. ESCs were washed once with PBS and split with 0.25% trypsin (GIBCO, 25200114). Cells were MEF depleted on 0.1% gelatinized plates for 30 min and then collected and counted. Cells were incubated with sgRNA lentivirus on low-attachment plates for 3 h in 2i medium (ESC-Media supplemented with 1 µM PD0325901 (Tocris, 4192) and 3 µM CHIR99021 (Tocris, 4423)) and were then plated onto 0.1% gelatin-coated plates at 12.5 × 10 4 cells/cm 2 . After 48 h, cells were split using 0.25% trypsin and plated in 2i medium supplemented with 1 µM puromycin to select for cells expressing the sgRNA. Transduced cells were maintained in 2i medium supplemented with 1 µM puromycin and split every 3 d. Cells were analyzed at the time of observed morphological changes (8-14 d after infection with sgRNA carrying lentivirus). To examine the effect of dCas9-LSD1 on local histone modifications, we analyzed cells 3 d before morphological changes were observed. To assess the requirement for LSD1 enzymatic activity, we carried out experiments in 2i medium supplemented with 500 nM trans-2-phenylcyclopropylamine hydrochloride (TCP) (Tocris 3852). After two passages, TCP was withdrawn where indicated, and cells were analyzed 14 d after TCP withdrawal.
Immunofluorescence analysis. Cells were fixed and processed as described 9 . Phase-contrast images were acquired on a Nikon Eclipse TS100 microscope using a 20× objective (Nikon LWD 20x/0.40 Ph1 ADL). Fluorescent images were acquired on a Nikon npg nature methods Eclipse Ti microscope using a 20× objective (Nikon S Plan Fluor ELWD 20x/0.45). We used filter cubes ET CY3 (Chroma, 49004), ET FITC (Chroma, 49002) and ET DAPI (Chroma, 49000) to isolate fluorescence from Alexa 594, Alexa 488 and Hoechst, respectively. Microscope and camera were controlled through NIS-Elements software (Nikon). Adobe Photoshop was used to apply linear contrast adjustments equally across all images. Further details are listed in the Supplementary Note. Antibodies were diluted as indicated in Supplementary Table 5 . OCT4-positive, OCT4-negative and mixed colonies were quantified using NIS-Elements Analysis Software. Between 520 and 1,300 colonies were identified for each condition by Hoechst staining of clusters comprising more than five cells. Colonies were scored as mixed if <50% of cells in the colony expressed OCT4.
Quantitative PCR analysis. Cells were trypsinized and washed once with PBS, and total RNA was isolated with Trizol reagent (Invitrogen, 15596-018) following the manufacturer's instructions. 1 µg of total RNA was reverse transcribed with the Superscript III First Strand Synthesis System (Invitrogen, 18080-051). 15 ng cDNA were used in quantitative PCR analyses with iTAQ Universal Sybr Green Supermix (Bio-Rad, 172-5124) with specific primers listed in Supplementary Table 6 . Relative gene expression was calculated using the ∆∆Ct method. All genes were normalized to Gapdh.
RNA-seq processing. RNA-seq data for ESCs and epiblast-like cells (EpiLCs) from a prior study 24 were downloaded from the Short Read Archive (SRP040451). The raw FASTQ files were processed using the UMass Medical School Bioinformatics Core Galaxy pipeline. Briefly, reads were aligned to the mouse ribosomal sequence and discarded from further analysis. Remaining reads were processed with RSEM 25 (version 1.2.7) using the RefSeq 26 gene annotation set for the mouse build GRCm38. The inferred transcripts per million (TPMs) values were used for further analysis. mESC-specific enhancer definition. Enhancers specific to ESC and EpiLC cellular states were identified on the basis of chromatin immunoprecipitation-sequencing (ChIP-seq) for the H3K27ac histone mark for each cell type 24 . Reads were aligned with Bowtie version 1.0.0 using "-v 0 -a --strata --best -m 1" parameters, and peaks were identified with MACS version 1.4.2 using "--tsize=35 --bw=300 -g 186550000. " Each peak called by MACS was initially considered a candidate enhancer. We then rescored the candidate peaks by way of a 300-nt moving window, advancing 10 nt for sequential windows as described 27 . An enrichment score, depth for H3K27ac as compared to the null, was associated to each window, and the maximum enrichment score across the windows was associated to the peaks. Any peaks with scores below a twofold enrichment relative to the null were filtered out. Low-quality peaks, with scores below the 60% quantile, were also filtered out. Each remaining peak was then trimmed according to the read depth associated to 50-nt moving windows. Ends were trimmed until a window score exceeding 20% of scale for the peak at hand was located. Each high-quality peak for one stage, EpiLC or ESC, was then compared to the other by scoring the trimmed region for the alternate stage. After adding a pseudocount of 10 to the score for each stage, those peaks exhibiting at least twofold enrichment were considered to be stage specific.
For each cell type, any stage-specific peak with the nearest gene transcription start site more than 5,000 bases away was identified as a potential distal enhancer. Peaks for which the nearest transcription start site was associated to a transcription factor were selected. To determine the strongest enhancer candidates for the ESC state, we further filtered the list to include only those peaks whose closest transcription factor exhibited at least a fourfold enrichment in TPM for the ESC state relative to the EpiLC state, after adding a pseudocount of 5 TPM for each stage. The resulting list contained 24 candidates (Supplementary Table 2) . We excluded the 13 intronic enhancers from further analysis. We also excluded enhancer chr8:72326162-72328532 as it was within 5,000 bases of a gene body and enhancer chr8:72332459-72335859 as it was closer to the gene body of a non-transcription factor than to the transcription factor KLF2. We chose to test two of the three candidates near KLF5 and all other remaining candidates, leaving eight putative distal enhancers that are listed in Supplementary Table 2a. ATAC-seq. Assay for transposase-accessible chromatin using sequencing (ATAC-seq) was performed on V6.5 mouse ESCs according to the protocol as described 28 . As starting material for the protocol, V6.5 mouse ESCs were grown on 0.1% gelatinized plates and maintained in 2i medium. Cells were harvested with 0.25% trypsin for 5 min, collected and counted. 50,000 cells were spun down at 500g for 5 min at 4 °C and washed once with 50 µL of cold PBS. ATAC-seq library generation and analysis occurred according to standard methodology 28 . Sequencing reads were mapped to the genome using Bowtie2 version 2.1.0 using the parameters "--phred33 -5 9 -3 2. " All ATAC-seq data are available through GEO under accession number GSE64059.
Microarray analysis.
Total RNA was isolated with Trizol reagent (Invitrogen, 15596-018) following the manufacturer's instructions either directly (Oct4 experiments) or after trypsinization (Tbx3 experiments). 250 ng of total RNA were amplified to generate labeled cRNA using the Illumina Total Prep RNA Amplification Kit (Ambion, AMIL1791). 750 ng of each labeled cRNA sample were hybridized to MouseRef-8 v2 Expression BeadChip (Illumina, BD-202-0202) and the chip scanned on an Illumina BeadArray Reader. Raw probe level data were exported from Illumina Bead Studio for further processing in R (http://www. r-project.org/). Raw probe level intensity values were adjusted using the R package limma 29 to apply quantile normalization and background subtraction and to transform to log 2 expression values. To identify differentially expressed genes, we ranked probes by highest difference in log 2 expression value between any two populations. Genes with log fold changes greater than 3 were used for the generation of hierarchically clustered heat maps. Data are displayed relative to the average log 2 expression signal in dCas9-effector-Ctrl sgRNA samples. In instances where multiple probes mapped to the same gene, only expression values for the highest ranked probe were retained. All gene expression data are available through GEO under accession number GSE64059.
Luciferase assay. Reporter plasmids containing a fragment of the Oct4 distal enhancer or putative Tbx3 distal enhancer were cloned into the pGL3-Promoter plasmid (Promega, E176A) upstream of an SV40 minimal promoter and firefly luciferase-encoding gene. 
